Aptar's Profitability Improving Due to Pharma Growth and Cost Controls
Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...
How much does it cost to make a penny, and are we ‘losing’ money on other coins?
In a move potentially foretold by the Department of Government Efficiency (DOGE), it seems the U.S. could be on the verge of ...